Capital Analysts LLC’s ANI Pharmaceuticals ANIP Stock Holding History
Bought
Maintained
Sold
Other funds holding ANIP
Capital Analysts LLC's ANIP Position: Q3 2026 in Review
Capital Analysts LLC opened a new position in ANI Pharmaceuticals (ANIP) in Q3 2026: 5 shares worth $363. The stake represents ﹤0.01% of the portfolio and ranks #1629 among its holdings.
290 funds tracked by Wall St. Rank hold ANIP as of Q3 2026.
- Capital Analysts LLC held 5 shares of ANI Pharmaceuticals worth $363 as of Q3 2026.
- ANI Pharmaceuticals was a new Capital Analysts LLC position in Q3 2026.
- ANI Pharmaceuticals made up ﹤0.01% of Capital Analysts LLC's portfolio in Q3 2026, its #1629 holding.
- 290 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q3 2026.
Based on Capital Analysts LLC's 13F filing for Q3 2026, filed 13 Nov 2026.